杜邦推出#tyvektogether增加的防护服供应

下载PDF.这里

威尔明顿，德尔。，德尔。，4月15日，2020年4月15日 - 杜邦（纽约证券交易所股票代码：DD）今天推出了一个新的程序，#tyvektogeth.在公司继续努力帮助打击Covid-19并保护医疗保健工作者的持续努力，提高Tyvek®个人防护服的整体可用性。全部能力，这一举措可以通过使他人加入我们保护更多的前线响应者来提供每月600万额外的非手术隔离礼服。 

“There’s a critical need for protective apparel, and we believe that working with other companies to convert their existing cut-and-sew manufacturing capacity to protective garment fabrication is the fastest way to protect more people,” said John Richard, Vice President & General Manager of DuPont Safety Solutions. “Our dedicated employees around the world are working 24/7 to make more Tyvek® material and patterns available to more organizations, working together to protect those who are protecting us.” 

杜邦投资了设备和技术，以显着增加其在全球范围内生产Tyvek®和Tychem®服装，以满足对个人保护设备（PPE）的不断增加的需求。自1月以来，我们每月每月生产超过900万件服装，专门针对Covid-19反应，这比任何现有危机产生的金额增加了两倍多。#tyvektogether程序将推出新的专业化Tyvek®面料，使Covid-19的服装生产量增加至每月1500万服装。 

 The #TyvekTogether Program includes the following components:

• 一种新的Fabric，Tyvek®风格1222A，具有与Core DupontTMTyvek®400服装产品具有类似的障碍性能，具有调整的织物悬垂和手，以优化材料使用。 

• Tyvek®风格1222A适用于具有可用Cut-And-Serfitive的现有和新客户的卷起形式，可以尽快增加Tyvek®服装的总量。  

• 杜邦将提供服装设计 - 包括模式和虚拟制造支持 - 用于非手术隔离礼服和针对简单和生产性制造而优化的套装。  With these patterns and technical assistance, we aim to accelerate the speed that new converters are able to begin producing PPE. 

• 合作伙伴还可以使用自己的设计，以满足当地需求。    

• 此外，杜邦公司将直接向受COVID-19影响最严重的美国各州捐赠超过5.7万件Tyvek®工作服 .  

杜邦安全与施工的杜邦个人保护部门仍然致力于帮助保护那些保护他人的人，特别是我们努力保护专门的工人在战斗Covid-19的前线。 For more information about the #TyvekTogether program, visit tyvektogether.dupont.com. 

有关杜邦完整的Covid-19回复工作的更多信息，请点击这里。

关于杜邦个人保护 

从急救人员到工业工人，杜邦提供了广泛的个人防护解决方案，包括一些最值得信赖的创新品牌，如凯夫拉®，Nomex®，Tyvek®和Tychem®，以满足您的安全需求。更多信息请访问www.personalprotection.dupont.com

关于杜邦安全与建筑  

杜邦安全与建筑公司是全球领先的创新公司，致力于为人们提供水、住所和安全方面的基本需求;使其客户通过独特的能力、全球规模和标志性品牌，包括可丽安®、凯夫拉®、诺美®、特卫克®、GreatStuff™、Styrofoam™和Filmtec®. 赢得客户

关于杜邦  

杜邦公司(NYSE: DD)是全球创新领导者，以科技为基础的材料、配料和解决方案帮助改变工业和日常生活。 我们的员工应用多种科学和专业知识，帮助客户在电子、交通、建筑、水、健康和保健、食品和工人安全等关键市场推进他们的最佳想法和提供必要的创新。 更多信息请访问www.lufeng-fst.com.／.

_{关于前瞻性陈述的警告声明}

_{该沟通在联邦证券法中的含义内包含“前瞻性陈述”，包括1933年的“证券法”第27A条，如修订，以及1934年证券交易所第21E条，如修订。在这方面，前瞻性陈述往往地满足预期的未来业务和财务绩效和财务状况，通常包含“期待”等词语“预期”，“打算”，“计划，”“求，”“求，”“请参阅，”“意志”，“\”，“目标，”和类似的表达和这些词的变化或否定。}

_{2019年4月1日，本公司通过职业奖励的所有Dow Inc.（“Dow Distribution”的所有杰出股票完成了物料科学业务分为单独和独立的公共公司。）。本公司于2019年6月1日完成了其农业业务将其农业业务分解为一家独立的独立公共公司，以Pro RATA股息的所有股票股票在Corteva，Inc。（“Corteva Distribution”（“Corteva Distribution”））。}

_{On December 15, 2019, DuPont and IFF announced they had entered definitive agreements to combine DuPont’s Nutrition & Biosciences business with IFF in a transaction that would result in IFF issuing shares to DuPont shareholders, pending customary closing conditions, other approvals including regulatory and that of IFF’s shareholders.}

_{前瞻性陈述涉及不同程度，不确定和受风险，不确定性和假设的事项，其中许多超出了杜邦的控制，这可能导致实际结果与任何前瞻性陈述中表达的结果不同。前瞻性陈述不保证未来结果。Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction with IFF; changes in relevant tax and other laws, (ii) failure to obtain necessary regulatory approvals, approval of IFF’s shareholders, anticipated tax treatment or any required financing or to satisfy any of the other conditions to the proposed transaction with IFF, (iii) the possibility that unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies that could impact the value, timing or pursuit of the proposed transaction with IFF, (iv) risks and costs and pursuit and/or implementation of the separation of the N&B Business, including timing anticipated to complete the separation, any changes to the configuration of businesses included in the separation if implemented, (v) risks and costs related to the Dow Distribution and the Corteva Distribution (together, the “Distributions”) including (a) with respect to achieving all expected benefits from the Distributions; (b) the incurrence of significant costs in connection with the Distributions, including costs to service debt incurred by the Company to establish the relative credit profiles of Corteva, Dow and DuPont and increased costs related to supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DuPont; (c) indemnification of certain legacy liabilities of E. I. du Pont de Nemours and Company ("Historical EID") in connection with the Corteva Distribution; and (d) potential liability arising from fraudulent conveyance and similar laws in connection with the Distributions; (vi) failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes, including meeting conditions under the Letter Agreement entered in connection with the Corteva Distribution, related to the transfer of certain levels of assets and businesses; (vii) uncertainty as to the long-term value of DuPont common stock; (viii) potential inability or reduced access to the capital markets or increased cost of borrowings, including as a result of a credit rating downgrade and (ix) other risks to DuPont's business, operations and results of operations including from: failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including tariffs, trade disputes and retaliatory actions; impairment of goodwill or intangible assets; the availability of and fluctuations in the cost of energy and raw materials; business or supply disruption, including in connection with the Distributions; ability to effectively manage costs as the company’s portfolio evolves; the unpredictability and inherent uncertainty in duration and extent of events including security threats, such as acts of sabotage, terrorism or war; natural disasters and weather events and patterns; public health issues, epidemics and pandemics, including the novel coronavirus (COVID-19) and the responses thereto (such as voluntary and in some cases, mandatory quarantines as well as shut downs and other restrictions on travel and commercial, social and other activities) which could or could continue to result in a significant operational event for DuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DuPont's intellectual property rights; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part I, Item 1A) of DuPont’s 2019 Annual Report on Form 10-K as updated by DuPont’s subsequent periodic and current reports filed with the SEC.}

#  #  #

04/15/20. 

下载媒体资产